1. Almost 1 million units of illegal medicines seized in Ireland

   News item 28 April 2018 Pages: 1 - 1

2. Health Canada: DRESS risk with six atypical antipsychotics

   News item 28 April 2018 Pages: 2 - 2

3. Health Canada: reminder about faulty contraceptive packages

   News item 28 April 2018 Pages: 3 - 3

4. PRAC meeting decisions re: methotrexate, HES solutions

   News item 28 April 2018 Pages: 4 - 4

5. Allopurinol-associated severe cutaneous adverse reactions

   Clinical study 28 April 2018 Pages: 5 - 5

6. Cardiovascular safety of smoking cessation therapies

   Clinical study 28 April 2018 Pages: 6 - 6

7. Major adverse cardiac events with DPP-4 inhibitors

   Clinical study 28 April 2018 Pages: 7 - 7

8. PGx test for statin-induced myopathy cost effective

   Clinical study 28 April 2018 Pages: 8 - 8

9. Risk of pancreatic cancer with CCBs in postmenopausal women

   Clinical study 28 April 2018 Pages: 9 - 9

10. Serious ADRs with sacubitril/valsartan: French survey results

    Clinical study 28 April 2018 Pages: 10 - 10

11. Serious adverse event and mortality report discrepancies

    Clinical study 28 April 2018 Pages: 11 - 11

12. Varicella vaccine: no increased risk of ischaemic stroke

    Clinical study 28 April 2018 Pages: 12 - 12

13. Acitretin

    Case report 28 April 2018 Pages: 13 - 13

14. Adalimumab/azathioprine/infliximab

    Case report 28 April 2018 Pages: 14 - 14

15. Adalimumab/infliximab

    Case report 28 April 2018 Pages: 15 - 15

16. Adalimumab/prednisone/vedolizumab

    Case report 28 April 2018 Pages: 16 - 16

17. Albiglutide/canagliflozin

    Case report 28 April 2018 Pages: 17 - 17

18. Alemtuzumab

    Case report 28 April 2018 Pages: 18 - 18

19. Alendronic acid/meloxicam/triamterene

    Case report 28 April 2018 Pages: 19 - 19

20. Alteplase

    Case report 28 April 2018 Pages: 20 - 20

21. Alteplase

    Case report 28 April 2018 Pages: 21 - 21

22. Amiodarone

    Case report 28 April 2018 Pages: 22 - 22

23. Amitriptyline

    Case report 28 April 2018 Pages: 23 - 23

24. Amoxicillin

    Case report 28 April 2018 Pages: 24 - 24

25. Amphotericin B liposomal/immunosuppressants

    Case report 28 April 2018 Pages: 25 - 25

26. Anticoagulants

    Case report 28 April 2018 Pages: 26 - 26

27. Antineoplastics

    Case report 28 April 2018 Pages: 27 - 27

28. Antineoplastics

    Case report 28 April 2018 Pages: 28 - 28

29. Antineoplastics

    Case report 28 April 2018 Pages: 29 - 29

30. Antineoplastics

    Case report 28 April 2018 Pages: 30 - 30

31. Antineoplastics

    Case report 28 April 2018 Pages: 31 - 31

32. Antineoplastics/antiretrovirals

    Case report 28 April 2018 Pages: 32 - 32

33. Antiplatelets/heparin/thrombolytics

    Case report 28 April 2018 Pages: 33 - 33

34. Antithymocyte globulin/muromonab-cd3

    Case report 28 April 2018 Pages: 34 - 34

35. Antivirals

    Case report 28 April 2018 Pages: 35 - 35

36. Antivirals

    Case report 28 April 2018 Pages: 36 - 36

37. Aspirin

    Case report 28 April 2018 Pages: 37 - 37

38. Aspirin/ibuprofen

    Case report 28 April 2018 Pages: 38 - 38

39. Atezolizumab/ipilimumab/nivolumab

    Case report 28 April 2018 Pages: 39 - 39

40. Atezolizumab/ipilimumab/pembrolizumab

    Case report 28 April 2018 Pages: 40 - 40

41. Atovaquone/proguanil

    Case report 28 April 2018 Pages: 41 - 41

42. Atropine

    Case report 28 April 2018 Pages: 42 - 42

43. Azathioprine/romiplostim

    Case report 28 April 2018 Pages: 43 - 43

44. Bemiparin sodium

    Case report 28 April 2018 Pages: 44 - 44

45. Bevacizumab

    Case report 28 April 2018 Pages: 45 - 45

46. Bevacizumab

    Case report 28 April 2018 Pages: 46 - 46

47. Bevacizumab

    Case report 28 April 2018 Pages: 47 - 47

48. Biotin

    Case report 28 April 2018 Pages: 48 - 48

49. Bivalirudin/heparin

    Case report 28 April 2018 Pages: 49 - 49

50. Bortezomib

    Case report 28 April 2018 Pages: 50 - 50